These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36189273)

  • 1. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
    Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
    Front Immunol; 2022; 13():953043. PubMed ID: 36189273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
    Signorelli F; Balbi GGM; Aikawa NE; Silva CA; Kupa LVK; Medeiros-Ribeiro AC; Yuki EF; Pasoto SG; Saad CG; Borba EF; Seguro LPC; Pedrosa T; Oliveira VAA; Costa ALCS; Ribeiro CT; Santos REB; Andrade DCO; Bonfá E
    Lupus; 2022 Jul; 31(8):974-984. PubMed ID: 35593174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study.
    Ceccarelli F; Natalucci F; Olivieri G; Pirone C; Picciariello L; Orefice V; Truglia S; Spinelli FR; Alessandri C; Chistolini A; Conti F
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2.
    Ogrič M; Žigon P; Sodin-Semrl S; Zlatković-Švenda M; Zdravković M; Ovuka M; Švec T; Lakota K; Radšel P; Rotar Ž; Čučnik S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single or triple positivity for antiphospholipid antibodies in "carriers" or symptomatic patients: Untangling the knot.
    Bertin D; Camoin-Jau L; Veit V; Resseguier N; Lambert M; Buffet Delmas P; Heim X; Mège JL; Morange PE; Bardin N
    J Thromb Haemost; 2021 Dec; 19(12):3018-3030. PubMed ID: 34469630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
    Gkrouzman E; Willis R; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Fortin PR; Gerosa M; Signorelli F; Atsumi T; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri MA; Cervera R; Knight JS; Efthymiou M; Cohen H; Bertolaccini ML; Erkan D; Roubey R;
    Lab Invest; 2023 Jun; 103(6):100147. PubMed ID: 37044248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19.
    Bertin D; Brodovitch A; Lopez A; Arcani R; Thomas GM; Beziane A; Weber S; Babacci B; Heim X; Rey L; Leone M; Mege JL; Bardin N
    Sci Rep; 2022 Jul; 12(1):12523. PubMed ID: 35869087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antiphospholipid antibodies in Takayasu arteritis.
    Şentürk EF; Erden A; Sarı A; Armağan B; Kılıç L; Kalyoncu U; Karadağ Ö; Bilgen ŞŞA; Kiraz S; Ertenli Aİ; Akdoğan A
    Turk J Med Sci; 2023 Feb; 53(1):199-205. PubMed ID: 36945962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms.
    Chayoua W; Kelchtermans H; Moore GW; Gris JC; Musial J; Wahl D; Zuily S; Gianniello F; Fontana P; Remijn J; Urbanus RT; de Laat B; Devreese KMJ
    Thromb Haemost; 2019 May; 119(5):797-806. PubMed ID: 30822809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome.
    Rottenstreich A; Arad A; Terespolsky H; Elchalal U; Amsalm H; Roth B; Kalish Y
    J Thromb Thrombolysis; 2018 Aug; 46(2):166-173. PubMed ID: 29713925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.